Literature DB >> 21402305

The time-dependent bias and its effect on extra length of stay due to nosocomial infection.

Adrian G Barnett1, Jan Beyersmann, Arthur Allignol, Victor D Rosenthal, Nicholas Graves, Martin Wolkewitz.   

Abstract

OBJECTIVES: Many studies disregard the time dependence of nosocomial infection when examining length of hospital stay and the associated financial costs. This leads to the "time-dependent bias," which biases multiplicative hazard ratios. We demonstrate the time-dependent bias on the additive scale of extra length of stay.
METHODS: To estimate the extra length of stay due to infection, we used a multistate model that accounted for the time of infection. For comparison we used a generalized linear model assuming a gamma distribution, a commonly used model that ignores the time of infection. We applied these two methods to a large prospective cohort of hospital admissions from Argentina, and compared the methods' performance using a simulation study.
RESULTS: For the Argentina data the extra length of stay due to nosocomial infection was 11.23 days when ignoring time dependence and only 1.35 days after accounting for the time of infection. The simulations showed that ignoring time dependence consistently overestimated the extra length of stay. This overestimation was similar for different rates of infection and even when an infection prolonged or shortened stay. We show examples where the time-dependent bias remains unchanged for the true discharge hazard ratios, but the bias for the extra length of stay is doubled because length of stay depends on the infection hazard.
CONCLUSIONS: Ignoring the timing of nosocomial infection gives estimates that greatly overestimate its effect on the extra length of hospital stay.
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21402305     DOI: 10.1016/j.jval.2010.09.008

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  33 in total

1.  The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system.

Authors:  Klaus Kaier; Martin Wolkewitz; Philip Hehn; Nico T Mutters; Thomas Heister
Journal:  Int J Health Econ Manag       Date:  2019-06-05

2.  Economic evaluation of quality improvement interventions to prevent catheter-associated urinary tract infections in the hospital setting: a systematic review.

Authors:  Sara G McCleskey; Lili Shek; Jonathan Grein; Hiroshi Gotanda; Laura Anderson; Paul G Shekelle; Emmett Keeler; Sally Morton; Teryl K Nuckols
Journal:  BMJ Qual Saf       Date:  2021-11-25       Impact factor: 7.418

3.  Disparity in race-specific comorbidities associated with central venous catheter-related bloodstream infection (AHRQ-PSI7).

Authors:  James Studnicki; Bola F Ekezue; Maka Tsulukidze; Peggy Honoré; Ramal Moonesinghe; John Fisher
Journal:  Am J Med Qual       Date:  2013-03-24       Impact factor: 1.852

4.  Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections.

Authors:  Brett G Mitchell; Anne Gardner
Journal:  Antimicrob Resist Infect Control       Date:  2012-04-20       Impact factor: 4.887

5.  Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureus.

Authors:  Tanya Gurieva; Martin C J Bootsma; Marc J M Bonten
Journal:  PLoS Comput Biol       Date:  2013-02-21       Impact factor: 4.475

6.  Open versus closed IV infusion systems: a state based model to predict risk of catheter associated blood stream infections.

Authors:  Nicholas Graves; Adrian G Barnett; Victor D Rosenthal
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

7.  Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan.

Authors:  Kazuma Yamakawa; Osamu Tasaki; Miyuki Fukuyama; Junichi Kitayama; Hiroki Matsuda; Yasushi Nakamori; Satoshi Fujimi; Hiroshi Ogura; Yasuyuki Kuwagata; Toshimitsu Hamasaki; Takeshi Shimazu
Journal:  BMC Infect Dis       Date:  2011-11-01       Impact factor: 3.090

8.  The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study.

Authors:  Adrian G Barnett; Katie Page; Megan Campbell; Elizabeth Martin; Rebecca Rashleigh-Rolls; Kate Halton; David L Paterson; Lisa Hall; Nerina Jimmieson; Katherine White; Nicholas Graves
Journal:  BMJ Open       Date:  2013-10-31       Impact factor: 2.692

9.  Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA.

Authors:  Sarah R Deeny; Colin J Worby; Olga Tosas Auguet; Ben S Cooper; Jonathan Edgeworth; Barry Cookson; Julie V Robotham
Journal:  J Antimicrob Chemother       Date:  2015-09-03       Impact factor: 5.790

10.  Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020.

Authors:  Laura Puzniak; Karri A Bauer; Kalvin C Yu; Pamela Moise; Lyn Finelli; Gang Ye; Carisa De Anda; Latha Vankeepuram; Vikas Gupta
Journal:  Open Forum Infect Dis       Date:  2021-05-26       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.